Covid-19 Impact on Global Neuropathic Pain Management Market Size, Status and Forecast 2020-2026

June 2020 | 99 pages | ID: C2D302E2F21EEN
QYResearch

Abstracts

This report focuses on the global Neuropathic Pain Management status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Neuropathic Pain Management development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Pfizer
• Johnson & Johnson Services
• Sanofi
• GlaxoSmithKline
• Eli Lilly and Company
• Bristol-Myers Squibb
• Biogen Idec
• Baxter Healthcare Corporation
• Depomed

Market segment by Type, the product can be split into

• Tricyclic Antidepressant
• Anticonvulsant
• Opioid
• Steroid Drug
• Local Anesthesia
• Other

Market segment by Application, split into

• Retail Pharmacy
• Hospital Pharmacy
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Neuropathic Pain Management status, future forecast, growth opportunity, key market and key players.
• To present the Neuropathic Pain Management development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Neuropathic Pain Management are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Neuropathic Pain Management Revenue
1.4 Market Analysis by Type
  1.4.1 Global Neuropathic Pain Management Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Tricyclic Antidepressant
  1.4.3 Anticonvulsant
  1.4.4 Opioid
  1.4.5 Steroid Drug
  1.4.6 Local Anesthesia
  1.4.7 Other
1.5 Market by Application
  1.5.1 Global Neuropathic Pain Management Market Share by Application: 2020 VS 2026
  1.5.2 Retail Pharmacy
  1.5.3 Hospital Pharmacy
  1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Neuropathic Pain Management Industry Impact
  1.6.1 How the Covid-19 is Affecting the Neuropathic Pain Management Industry
    1.6.1.1 Neuropathic Pain Management Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Neuropathic Pain Management Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Neuropathic Pain Management Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Neuropathic Pain Management Market Perspective (2015-2026)
2.2 Neuropathic Pain Management Growth Trends by Regions
  2.2.1 Neuropathic Pain Management Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Neuropathic Pain Management Historic Market Share by Regions (2015-2020)
  2.2.3 Neuropathic Pain Management Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Neuropathic Pain Management Market Growth Strategy
  2.3.6 Primary Interviews with Key Neuropathic Pain Management Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Neuropathic Pain Management Players by Market Size
  3.1.1 Global Top Neuropathic Pain Management Players by Revenue (2015-2020)
  3.1.2 Global Neuropathic Pain Management Revenue Market Share by Players (2015-2020)
  3.1.3 Global Neuropathic Pain Management Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Neuropathic Pain Management Market Concentration Ratio
  3.2.1 Global Neuropathic Pain Management Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Neuropathic Pain Management Revenue in 2019
3.3 Neuropathic Pain Management Key Players Head office and Area Served
3.4 Key Players Neuropathic Pain Management Product Solution and Service
3.5 Date of Enter into Neuropathic Pain Management Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Neuropathic Pain Management Historic Market Size by Type (2015-2020)
4.2 Global Neuropathic Pain Management Forecasted Market Size by Type (2021-2026)

5 NEUROPATHIC PAIN MANAGEMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Neuropathic Pain Management Market Size by Application (2015-2020)
5.2 Global Neuropathic Pain Management Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Neuropathic Pain Management Market Size (2015-2020)
6.2 Neuropathic Pain Management Key Players in North America (2019-2020)
6.3 North America Neuropathic Pain Management Market Size by Type (2015-2020)
6.4 North America Neuropathic Pain Management Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Neuropathic Pain Management Market Size (2015-2020)
7.2 Neuropathic Pain Management Key Players in Europe (2019-2020)
7.3 Europe Neuropathic Pain Management Market Size by Type (2015-2020)
7.4 Europe Neuropathic Pain Management Market Size by Application (2015-2020)

8 CHINA

8.1 China Neuropathic Pain Management Market Size (2015-2020)
8.2 Neuropathic Pain Management Key Players in China (2019-2020)
8.3 China Neuropathic Pain Management Market Size by Type (2015-2020)
8.4 China Neuropathic Pain Management Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Neuropathic Pain Management Market Size (2015-2020)
9.2 Neuropathic Pain Management Key Players in Japan (2019-2020)
9.3 Japan Neuropathic Pain Management Market Size by Type (2015-2020)
9.4 Japan Neuropathic Pain Management Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Neuropathic Pain Management Market Size (2015-2020)
10.2 Neuropathic Pain Management Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Neuropathic Pain Management Market Size by Type (2015-2020)
10.4 Southeast Asia Neuropathic Pain Management Market Size by Application (2015-2020)

11 INDIA

11.1 India Neuropathic Pain Management Market Size (2015-2020)
11.2 Neuropathic Pain Management Key Players in India (2019-2020)
11.3 India Neuropathic Pain Management Market Size by Type (2015-2020)
11.4 India Neuropathic Pain Management Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Neuropathic Pain Management Market Size (2015-2020)
12.2 Neuropathic Pain Management Key Players in Central & South America (2019-2020)
12.3 Central & South America Neuropathic Pain Management Market Size by Type (2015-2020)
12.4 Central & South America Neuropathic Pain Management Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Pfizer
  13.1.1 Pfizer Company Details
  13.1.2 Pfizer Business Overview and Its Total Revenue
  13.1.3 Pfizer Neuropathic Pain Management Introduction
  13.1.4 Pfizer Revenue in Neuropathic Pain Management Business (2015-2020))
  13.1.5 Pfizer Recent Development
13.2 Johnson & Johnson Services
  13.2.1 Johnson & Johnson Services Company Details
  13.2.2 Johnson & Johnson Services Business Overview and Its Total Revenue
  13.2.3 Johnson & Johnson Services Neuropathic Pain Management Introduction
  13.2.4 Johnson & Johnson Services Revenue in Neuropathic Pain Management Business (2015-2020)
  13.2.5 Johnson & Johnson Services Recent Development
13.3 Sanofi
  13.3.1 Sanofi Company Details
  13.3.2 Sanofi Business Overview and Its Total Revenue
  13.3.3 Sanofi Neuropathic Pain Management Introduction
  13.3.4 Sanofi Revenue in Neuropathic Pain Management Business (2015-2020)
  13.3.5 Sanofi Recent Development
13.4 GlaxoSmithKline
  13.4.1 GlaxoSmithKline Company Details
  13.4.2 GlaxoSmithKline Business Overview and Its Total Revenue
  13.4.3 GlaxoSmithKline Neuropathic Pain Management Introduction
  13.4.4 GlaxoSmithKline Revenue in Neuropathic Pain Management Business (2015-2020)
  13.4.5 GlaxoSmithKline Recent Development
13.5 Eli Lilly and Company
  13.5.1 Eli Lilly and Company Company Details
  13.5.2 Eli Lilly and Company Business Overview and Its Total Revenue
  13.5.3 Eli Lilly and Company Neuropathic Pain Management Introduction
  13.5.4 Eli Lilly and Company Revenue in Neuropathic Pain Management Business (2015-2020)
  13.5.5 Eli Lilly and Company Recent Development
13.6 Bristol-Myers Squibb
  13.6.1 Bristol-Myers Squibb Company Details
  13.6.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
  13.6.3 Bristol-Myers Squibb Neuropathic Pain Management Introduction
  13.6.4 Bristol-Myers Squibb Revenue in Neuropathic Pain Management Business (2015-2020)
  13.6.5 Bristol-Myers Squibb Recent Development
13.7 Biogen Idec
  13.7.1 Biogen Idec Company Details
  13.7.2 Biogen Idec Business Overview and Its Total Revenue
  13.7.3 Biogen Idec Neuropathic Pain Management Introduction
  13.7.4 Biogen Idec Revenue in Neuropathic Pain Management Business (2015-2020)
  13.7.5 Biogen Idec Recent Development
13.8 Baxter Healthcare Corporation
  13.8.1 Baxter Healthcare Corporation Company Details
  13.8.2 Baxter Healthcare Corporation Business Overview and Its Total Revenue
  13.8.3 Baxter Healthcare Corporation Neuropathic Pain Management Introduction
  13.8.4 Baxter Healthcare Corporation Revenue in Neuropathic Pain Management Business (2015-2020)
  13.8.5 Baxter Healthcare Corporation Recent Development
13.9 Depomed
  13.9.1 Depomed Company Details
  13.9.2 Depomed Business Overview and Its Total Revenue
  13.9.3 Depomed Neuropathic Pain Management Introduction
  13.9.4 Depomed Revenue in Neuropathic Pain Management Business (2015-2020)
  13.9.5 Depomed Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Neuropathic Pain Management Key Market Segments
Table 2. Key Players Covered: Ranking by Neuropathic Pain Management Revenue
Table 3. Ranking of Global Top Neuropathic Pain Management Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Neuropathic Pain Management Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Tricyclic Antidepressant
Table 6. Key Players of Anticonvulsant
Table 7. Key Players of Opioid
Table 8. Key Players of Steroid Drug
Table 9. Key Players of Local Anesthesia
Table 10. Key Players of Other
Table 11. COVID-19 Impact Global Market: (Four Neuropathic Pain Management Market Size Forecast Scenarios)
Table 12. Opportunities and Trends for Neuropathic Pain Management Players in the COVID-19 Landscape
Table 13. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 14. Key Regions/Countries Measures against Covid-19 Impact
Table 15. Proposal for Neuropathic Pain Management Players to Combat Covid-19 Impact
Table 16. Global Neuropathic Pain Management Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 17. Global Neuropathic Pain Management Market Size by Regions (US$ Million): 2020 VS 2026
Table 18. Global Neuropathic Pain Management Market Size by Regions (2015-2020) (US$ Million)
Table 19. Global Neuropathic Pain Management Market Share by Regions (2015-2020)
Table 20. Global Neuropathic Pain Management Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 21. Global Neuropathic Pain Management Market Share by Regions (2021-2026)
Table 22. Market Top Trends
Table 23. Key Drivers: Impact Analysis
Table 24. Key Challenges
Table 25. Neuropathic Pain Management Market Growth Strategy
Table 26. Main Points Interviewed from Key Neuropathic Pain Management Players
Table 27. Global Neuropathic Pain Management Revenue by Players (2015-2020) (Million US$)
Table 28. Global Neuropathic Pain Management Market Share by Players (2015-2020)
Table 29. Global Top Neuropathic Pain Management Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuropathic Pain Management as of 2019)
Table 30. Global Neuropathic Pain Management by Players Market Concentration Ratio (CR5 and HHI)
Table 31. Key Players Headquarters and Area Served
Table 32. Key Players Neuropathic Pain Management Product Solution and Service
Table 33. Date of Enter into Neuropathic Pain Management Market
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Neuropathic Pain Management Market Size by Type (2015-2020) (Million US$)
Table 36. Global Neuropathic Pain Management Market Size Share by Type (2015-2020)
Table 37. Global Neuropathic Pain Management Revenue Market Share by Type (2021-2026)
Table 38. Global Neuropathic Pain Management Market Size Share by Application (2015-2020)
Table 39. Global Neuropathic Pain Management Market Size by Application (2015-2020) (Million US$)
Table 40. Global Neuropathic Pain Management Market Size Share by Application (2021-2026)
Table 41. North America Key Players Neuropathic Pain Management Revenue (2019-2020) (Million US$)
Table 42. North America Key Players Neuropathic Pain Management Market Share (2019-2020)
Table 43. North America Neuropathic Pain Management Market Size by Type (2015-2020) (Million US$)
Table 44. North America Neuropathic Pain Management Market Share by Type (2015-2020)
Table 45. North America Neuropathic Pain Management Market Size by Application (2015-2020) (Million US$)
Table 46. North America Neuropathic Pain Management Market Share by Application (2015-2020)
Table 47. Europe Key Players Neuropathic Pain Management Revenue (2019-2020) (Million US$)
Table 48. Europe Key Players Neuropathic Pain Management Market Share (2019-2020)
Table 49. Europe Neuropathic Pain Management Market Size by Type (2015-2020) (Million US$)
Table 50. Europe Neuropathic Pain Management Market Share by Type (2015-2020)
Table 51. Europe Neuropathic Pain Management Market Size by Application (2015-2020) (Million US$)
Table 52. Europe Neuropathic Pain Management Market Share by Application (2015-2020)
Table 53. China Key Players Neuropathic Pain Management Revenue (2019-2020) (Million US$)
Table 54. China Key Players Neuropathic Pain Management Market Share (2019-2020)
Table 55. China Neuropathic Pain Management Market Size by Type (2015-2020) (Million US$)
Table 56. China Neuropathic Pain Management Market Share by Type (2015-2020)
Table 57. China Neuropathic Pain Management Market Size by Application (2015-2020) (Million US$)
Table 58. China Neuropathic Pain Management Market Share by Application (2015-2020)
Table 59. Japan Key Players Neuropathic Pain Management Revenue (2019-2020) (Million US$)
Table 60. Japan Key Players Neuropathic Pain Management Market Share (2019-2020)
Table 61. Japan Neuropathic Pain Management Market Size by Type (2015-2020) (Million US$)
Table 62. Japan Neuropathic Pain Management Market Share by Type (2015-2020)
Table 63. Japan Neuropathic Pain Management Market Size by Application (2015-2020) (Million US$)
Table 64. Japan Neuropathic Pain Management Market Share by Application (2015-2020)
Table 65. Southeast Asia Key Players Neuropathic Pain Management Revenue (2019-2020) (Million US$)
Table 66. Southeast Asia Key Players Neuropathic Pain Management Market Share (2019-2020)
Table 67. Southeast Asia Neuropathic Pain Management Market Size by Type (2015-2020) (Million US$)
Table 68. Southeast Asia Neuropathic Pain Management Market Share by Type (2015-2020)
Table 69. Southeast Asia Neuropathic Pain Management Market Size by Application (2015-2020) (Million US$)
Table 70. Southeast Asia Neuropathic Pain Management Market Share by Application (2015-2020)
Table 71. India Key Players Neuropathic Pain Management Revenue (2019-2020) (Million US$)
Table 72. India Key Players Neuropathic Pain Management Market Share (2019-2020)
Table 73. India Neuropathic Pain Management Market Size by Type (2015-2020) (Million US$)
Table 74. India Neuropathic Pain Management Market Share by Type (2015-2020)
Table 75. India Neuropathic Pain Management Market Size by Application (2015-2020) (Million US$)
Table 76. India Neuropathic Pain Management Market Share by Application (2015-2020)
Table 77. Central & South America Key Players Neuropathic Pain Management Revenue (2019-2020) (Million US$)
Table 78. Central & South America Key Players Neuropathic Pain Management Market Share (2019-2020)
Table 79. Central & South America Neuropathic Pain Management Market Size by Type (2015-2020) (Million US$)
Table 80. Central & South America Neuropathic Pain Management Market Share by Type (2015-2020)
Table 81. Central & South America Neuropathic Pain Management Market Size by Application (2015-2020) (Million US$)
Table 82. Central & South America Neuropathic Pain Management Market Share by Application (2015-2020)
Table 83. Pfizer Company Details
Table 84. Pfizer Business Overview
Table 85. Pfizer Product
Table 86. Pfizer Revenue in Neuropathic Pain Management Business (2015-2020) (Million US$)
Table 87. Pfizer Recent Development
Table 88. Johnson & Johnson Services Company Details
Table 89. Johnson & Johnson Services Business Overview
Table 90. Johnson & Johnson Services Product
Table 91. Johnson & Johnson Services Revenue in Neuropathic Pain Management Business (2015-2020) (Million US$)
Table 92. Johnson & Johnson Services Recent Development
Table 93. Sanofi Company Details
Table 94. Sanofi Business Overview
Table 95. Sanofi Product
Table 96. Sanofi Revenue in Neuropathic Pain Management Business (2015-2020) (Million US$)
Table 97. Sanofi Recent Development
Table 98. GlaxoSmithKline Company Details
Table 99. GlaxoSmithKline Business Overview
Table 100. GlaxoSmithKline Product
Table 101. GlaxoSmithKline Revenue in Neuropathic Pain Management Business (2015-2020) (Million US$)
Table 102. GlaxoSmithKline Recent Development
Table 103. Eli Lilly and Company Company Details
Table 104. Eli Lilly and Company Business Overview
Table 105. Eli Lilly and Company Product
Table 106. Eli Lilly and Company Revenue in Neuropathic Pain Management Business (2015-2020) (Million US$)
Table 107. Eli Lilly and Company Recent Development
Table 108. Bristol-Myers Squibb Company Details
Table 109. Bristol-Myers Squibb Business Overview
Table 110. Bristol-Myers Squibb Product
Table 111. Bristol-Myers Squibb Revenue in Neuropathic Pain Management Business (2015-2020) (Million US$)
Table 112. Bristol-Myers Squibb Recent Development
Table 113. Biogen Idec Company Details
Table 114. Biogen Idec Business Overview
Table 115. Biogen Idec Product
Table 116. Biogen Idec Revenue in Neuropathic Pain Management Business (2015-2020) (Million US$)
Table 117. Biogen Idec Recent Development
Table 118. Baxter Healthcare Corporation Business Overview
Table 119. Baxter Healthcare Corporation Product
Table 120. Baxter Healthcare Corporation Company Details
Table 121. Baxter Healthcare Corporation Revenue in Neuropathic Pain Management Business (2015-2020) (Million US$)
Table 122. Baxter Healthcare Corporation Recent Development
Table 123. Depomed Company Details
Table 124. Depomed Business Overview
Table 125. Depomed Product
Table 126. Depomed Revenue in Neuropathic Pain Management Business (2015-2020) (Million US$)
Table 127. Depomed Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Neuropathic Pain Management Market Share by Type: 2020 VS 2026
Figure 2. Tricyclic Antidepressant Features
Figure 3. Anticonvulsant Features
Figure 4. Opioid Features
Figure 5. Steroid Drug Features
Figure 6. Local Anesthesia Features
Figure 7. Other Features
Figure 8. Global Neuropathic Pain Management Market Share by Application: 2020 VS 2026
Figure 9. Retail Pharmacy Case Studies
Figure 10. Hospital Pharmacy Case Studies
Figure 11. Other Case Studies
Figure 12. Neuropathic Pain Management Report Years Considered
Figure 13. Global Neuropathic Pain Management Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Neuropathic Pain Management Market Share by Regions: 2020 VS 2026
Figure 15. Global Neuropathic Pain Management Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Neuropathic Pain Management Market Share by Players in 2019
Figure 18. Global Top Neuropathic Pain Management Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuropathic Pain Management as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Neuropathic Pain Management Revenue in 2019
Figure 20. North America Neuropathic Pain Management Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Neuropathic Pain Management Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Neuropathic Pain Management Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Neuropathic Pain Management Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Neuropathic Pain Management Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Neuropathic Pain Management Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Neuropathic Pain Management Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Pfizer Revenue Growth Rate in Neuropathic Pain Management Business (2015-2020)
Figure 29. Johnson & Johnson Services Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Johnson & Johnson Services Revenue Growth Rate in Neuropathic Pain Management Business (2015-2020)
Figure 31. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Sanofi Revenue Growth Rate in Neuropathic Pain Management Business (2015-2020)
Figure 33. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. GlaxoSmithKline Revenue Growth Rate in Neuropathic Pain Management Business (2015-2020)
Figure 35. Eli Lilly and Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Eli Lilly and Company Revenue Growth Rate in Neuropathic Pain Management Business (2015-2020)
Figure 37. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Bristol-Myers Squibb Revenue Growth Rate in Neuropathic Pain Management Business (2015-2020)
Figure 39. Biogen Idec Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Biogen Idec Revenue Growth Rate in Neuropathic Pain Management Business (2015-2020)
Figure 41. Baxter Healthcare Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Baxter Healthcare Corporation Revenue Growth Rate in Neuropathic Pain Management Business (2015-2020)
Figure 43. Depomed Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Depomed Revenue Growth Rate in Neuropathic Pain Management Business (2015-2020)
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed